|
DZ2376A1
(fr)
*
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
JP2002511097A
(ja)
|
1997-07-11 |
2002-04-09 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
５−ｈｔ▲下６▼レセプターアンタゴニストであるスルホンアミド誘導体およびその製造方法
|
|
EP1053227B1
(en)
|
1998-01-29 |
2008-11-05 |
Amgen Inc. |
Ppar-gamma modulators
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
GB9810671D0
(en)
*
|
1998-05-18 |
1998-07-15 |
Pfizer Ltd |
Anti-pruritic agents
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9818916D0
(en)
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9820113D0
(en)
|
1998-09-15 |
1998-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
GB9926302D0
(en)
*
|
1999-11-05 |
2000-01-12 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP2003518057A
(ja)
*
|
1999-12-21 |
2003-06-03 |
スミスクライン・ビーチャム・コーポレイション |
ウロテンシン−ｉｉ受容体アンタゴニスト
|
|
SE9904723D0
(sv)
*
|
1999-12-22 |
1999-12-22 |
Carlsson A Research Ab |
New modulators of dopamine neurotransmission II
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
US6399617B1
(en)
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
SE0002754D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New pharmaceutical combination formulation and method of treatment with the combination
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
US6818639B2
(en)
|
2000-07-21 |
2004-11-16 |
Biovitrum Ab |
Pharmaceutical combination formulation and method of treatment with the combination
|
|
ATE478857T1
(de)
*
|
2000-09-18 |
2010-09-15 |
Toa Eiyo Ltd |
N-substituierte benzothiophensulfonamid-derivate
|
|
US7071220B2
(en)
|
2000-09-18 |
2006-07-04 |
Toa Eiyo Ltd. |
N-substituted benzothiophenesulfonamide derivatives
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
AU2002215047A1
(en)
|
2000-11-21 |
2002-06-03 |
Smithkline Beecham Plc |
Isoquinoline derivatives useful in the treatment of cns disorders
|
|
EP1344525A4
(en)
|
2000-12-22 |
2005-05-25 |
Ishihara Sangyo Kaisha |
ANILINE DERIVATIVES OR ITS SALTS AND CYTOKINE PRODUCTION INHIBITORS CONTAINING THEM
|
|
WO2002088101A2
(en)
*
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
|
US6743796B2
(en)
|
2001-05-07 |
2004-06-01 |
Wyeth |
Piperazinyl-isatins
|
|
AR033879A1
(es)
*
|
2001-05-07 |
2004-01-07 |
Smithkline Beecham Corp |
Compuesto sulfonamida, composicion farmaceutica que lo comprende, su uso para preparar dicha composicion y procedimiento para la obtencion de dicho compuesto
|
|
AU2002256497A1
(en)
*
|
2001-05-07 |
2002-11-18 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
JP2004529168A
(ja)
*
|
2001-05-07 |
2004-09-24 |
スミスクライン・ビーチャム・コーポレイション |
スルホンアミド
|
|
JP2004529164A
(ja)
*
|
2001-05-07 |
2004-09-24 |
スミスクライン・ビーチャム・コーポレイション |
スルホンアミド
|
|
EP1399137A4
(en)
*
|
2001-05-07 |
2005-12-14 |
Smithkline Beecham Corp |
SULPHONAMIDES
|
|
GB0111186D0
(en)
*
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
RS88803A
(sr)
*
|
2001-05-11 |
2007-02-05 |
Biovitrum Ab., |
Nova jedinjenja arilsulfonamida za lečenje gojaznosti, dijabetesa tipa ii i poremećaja cns
|
|
NZ528450A
(en)
|
2001-05-11 |
2006-02-24 |
Biovitrum Ab |
Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders
|
|
JP4187642B2
(ja)
|
2001-06-07 |
2008-11-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６受容体親和性を有する新規インドール誘導体
|
|
KR20090019894A
(ko)
|
2001-06-11 |
2009-02-25 |
바이오비트럼 에이비(피유비엘) |
치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형 당뇨병 치료용 약제로서의 이들의 사용 방법
|
|
ES2268113T3
(es)
|
2001-06-15 |
2007-03-16 |
F. Hoffmann-La Roche Ag |
Derivados de 4-piperazinilindol con afinidad al receptor 5-ht6.
|
|
US6727264B1
(en)
|
2001-07-05 |
2004-04-27 |
Synaptic Pharmaceutical Corporation |
Substituted anilinic piperidines as MCH selective antagonists
|
|
JP2005527463A
(ja)
*
|
2001-08-07 |
2005-09-15 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
|
|
MXPA04001250A
(es)
*
|
2001-08-10 |
2004-05-27 |
Hoffmann La Roche |
Derivados de arilsulfonilo con afinidad receptora de 5-hidroxitriptamina6 (5-ht6).
|
|
EP1433479B8
(en)
*
|
2001-09-05 |
2008-01-23 |
Eisai R&D Management Co., Ltd. |
Appetite-stimulating agents and remedies for anorexia
|
|
SE0103644D0
(sv)
*
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
|
EP1450806B1
(en)
*
|
2001-11-09 |
2009-04-29 |
Biovitrum AB (publ) |
Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake
|
|
RS44204A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
RS44304A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
ATE367160T1
(de)
*
|
2001-11-30 |
2007-08-15 |
Hoffmann La Roche |
Piperazin-derivate zur verwendung als ccr-3 rezeptor antagonisten zur behandlung von asthma
|
|
CN1628109A
(zh)
*
|
2002-02-05 |
2005-06-15 |
诺沃挪第克公司 |
新颖的芳基－与杂芳基－哌嗪
|
|
US20070270432A1
(en)
*
|
2002-02-05 |
2007-11-22 |
James Hagan |
Novel Method
|
|
EP1495004A2
(en)
*
|
2002-02-13 |
2005-01-12 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
|
|
US20050090485A1
(en)
*
|
2002-02-13 |
2005-04-28 |
Bromidge Steven M. |
7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders
|
|
US20050222124A1
(en)
*
|
2002-02-13 |
2005-10-06 |
Bromidge Steven M |
Benzenesulfonamide derivatives as antipsychotic agents
|
|
ES2386828T3
(es)
|
2002-03-27 |
2012-08-31 |
Glaxo Group Limited |
Derivados de quinolina y su uso como ligandos 5-HT6
|
|
US20040142948A1
(en)
*
|
2002-05-07 |
2004-07-22 |
Dashyant Dhanak |
Sulfonamides
|
|
KR100636475B1
(ko)
*
|
2002-05-13 |
2006-10-18 |
에프. 호프만-라 로슈 아게 |
5-ｈｔ6 조절제로서 벤족사진 유도체 및 이의 용도
|
|
NZ552282A
(en)
*
|
2002-06-20 |
2008-07-31 |
Biovitrum Ab Publ |
New compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
US7943639B2
(en)
*
|
2002-06-20 |
2011-05-17 |
Proximagen Limited |
Compounds
|
|
EP1897881A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
WO2004035047A1
(en)
|
2002-10-18 |
2004-04-29 |
F. Hoffmann-La Roche Ag |
4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
|
|
WO2004043369A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
WO2004043368A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
KR101078098B1
(ko)
|
2003-01-14 |
2011-10-28 |
아레나 파마슈티칼스, 인크. |
대사 조절제로서의 １,２,３-삼치환된 아릴 및 헤테로아릴유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된장애의 예방 및 치료
|
|
US7153858B2
(en)
|
2003-01-31 |
2006-12-26 |
Epix Delaware, Inc. |
Arylpiperazinyl compounds
|
|
EP1597322A2
(de)
*
|
2003-02-13 |
2005-11-23 |
LANXESS Deutschland GmbH |
Metallkomplexe als lichtabsorbierende verbindungen in der informationsschicht von optischen datenträgern
|
|
EP2415760A3
(en)
*
|
2003-02-20 |
2012-02-22 |
Encysive Pharmaceuticals, Inc. |
CCR-9 antagonists
|
|
TWI289141B
(en)
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
US7262197B2
(en)
*
|
2003-03-31 |
2007-08-28 |
Janssen Pharmaceutica, N.V |
Phospholipase C inhibitors for use in treating inflammatory disorders
|
|
US6946466B2
(en)
*
|
2003-04-10 |
2005-09-20 |
Schering Ag |
Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
|
|
US20040204422A1
(en)
*
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
US8754238B2
(en)
|
2003-07-22 |
2014-06-17 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
GB0320320D0
(en)
*
|
2003-08-29 |
2003-10-01 |
Glaxo Group Ltd |
Novel compounds
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
SE0303480D0
(sv)
*
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
WO2005058858A1
(en)
*
|
2003-12-19 |
2005-06-30 |
Biovitrum Ab |
Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
|
|
RU2007107349A
(ru)
*
|
2004-07-28 |
2008-09-10 |
Глэксо Груп Лимитед (GB) |
Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств
|
|
ES2359725T3
(es)
*
|
2004-09-30 |
2011-05-26 |
F. Hoffmann-La Roche Ag |
Composiciones y métodos para el tratamiento de trastornos cognitivos.
|
|
ATE520659T1
(de)
|
2004-10-14 |
2011-09-15 |
Abbott Gmbh & Co Kg |
Zur behandlung von auf die modulation des dopamin-d3-rezeptors ansprechenden erkrankungen geeignete azabicycloheptylverbindungen
|
|
CA2583983C
(en)
*
|
2004-10-14 |
2013-07-16 |
Abbott Gmbh & Co. Kg |
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
|
|
WO2006062481A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Biovitrum Ab |
New benzofuran derivatives and their use in the treatment of obesity, type ii diabetes and cns disorders .
|
|
EP1676841A1
(en)
*
|
2004-12-30 |
2006-07-05 |
Esteve Laboratorios Dr. Esteve S.A. |
Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
|
|
WO2006075808A1
(en)
*
|
2005-01-12 |
2006-07-20 |
Inje University |
Pharmaceutical composition comprising a p25/cdk5 inhibitor for preventing or treating a neurodegenerative disease
|
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
|
EA013875B1
(ru)
|
2005-08-12 |
2010-08-30 |
Сувен Лайф Сайенсиз Лимитед |
Аминоарильные сульфонамидные производные как функциональные 5-нтлиганды
|
|
US7923566B2
(en)
|
2005-08-16 |
2011-04-12 |
Suven Life Sciences Limited |
Alternative process for the preparation of losartan
|
|
US20100048713A1
(en)
*
|
2006-01-06 |
2010-02-25 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
PE20080176A1
(es)
|
2006-03-31 |
2008-04-25 |
Glaxo Group Ltd |
Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs)
|
|
MX2008013206A
(es)
|
2006-04-19 |
2008-10-22 |
Abbott Gmbh & Co Kg |
Compuestos heterociclicos adecuados para el tratamiento de trastornos que responden a modulacion del receptor de serotonina 5ht6.
|
|
CN101421234A
(zh)
*
|
2006-04-19 |
2009-04-29 |
艾博特股份有限两合公司 |
适于治疗对5-羟色胺5ht6受体调节有反应的病症的杂环芳基砜
|
|
CA2653062A1
(en)
|
2006-05-23 |
2007-11-29 |
Transtech Pharma, Inc. |
6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
|
|
KR20090040259A
(ko)
|
2006-05-29 |
2009-04-23 |
하이 포인트 파마슈티칼스, 엘엘씨 |
3-(1,3-벤조디옥솔-5-일)-6-(4-시클로프로필피페라진-1-일)-피리다진, 그것의 염과 용매화합물 및 그것의 히스타민 ｈ3 수용체 안타고니스트로서의 용도
|
|
EP2086329B1
(en)
|
2006-10-26 |
2014-07-23 |
The Arizona Board of Regents on behalf of the University of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
ES2357584T3
(es)
|
2007-01-08 |
2011-04-27 |
Suven Life Sciences Limited |
Compuestos de 5-(heterociclil) alquil-n-(arilsulfonil)indol y su uso como ligandos de 5-th6.
|
|
CN101578265B
(zh)
|
2007-01-10 |
2013-05-08 |
霍夫曼-拉罗奇有限公司 |
用作糜蛋白酶抑制剂的磺酰胺衍生物
|
|
EP2155724A1
(en)
|
2007-03-23 |
2010-02-24 |
Abbott GmbH & Co. KG |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
EA016594B1
(ru)
|
2007-05-03 |
2012-06-29 |
Сувен Лайф Сайенсиз Лимитед |
Производные 1-(аминоалкоксиарилсульфонил)индола в качестве 5-нтлигандов
|
|
EP2014656A3
(en)
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
DE602007012683D1
(de)
*
|
2007-07-19 |
2011-04-07 |
Esteve Labor Dr |
Substituierte Tetrahydro-Chinolinsulfonamidverbindungen, ihre Herstellung und ihre Verwendung als Medikamente
|
|
CA2703157C
(en)
|
2007-10-26 |
2013-02-05 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-ht6 ligands
|
|
PA8802201A1
(es)
*
|
2007-11-02 |
2009-06-23 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
|
|
US9084742B2
(en)
|
2007-12-12 |
2015-07-21 |
Axovant Sciences Ltd. |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
|
|
US20110021538A1
(en)
|
2008-04-02 |
2011-01-27 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
EA201001847A1
(ru)
*
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
WO2010032258A1
(en)
*
|
2008-09-17 |
2010-03-25 |
Suven Life Sciences Limited |
Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
UA100192C2
(en)
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
KR101073703B1
(ko)
|
2009-04-07 |
2011-10-14 |
한국화학연구원 |
피페라진 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환의 예방 또는 치료용 약학적 조성물
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8362010B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
MX2011011519A
(es)
|
2009-04-30 |
2012-01-30 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
|
|
CN102459197B
(zh)
|
2009-04-30 |
2015-08-19 |
Abbvie公司 |
适用于治疗响应血清素5-ht6受体的调节的病症的n-苯基-(哌嗪基或高哌嗪基)-苯磺酰胺或苯磺酰基-苯基-(哌嗪或高哌嗪)化合物
|
|
KR101463190B1
(ko)
|
2010-01-05 |
2014-11-18 |
수벤 라이프 사이언시스 리미티드 |
５ｈｔ６ 수용체 리간드인 술폰 화합물
|
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
ES2413911B1
(es)
*
|
2011-12-15 |
2014-05-14 |
Universidad De Zaragoza |
Agente inhibidor de la agregación del peptido beta amiloide.
|
|
NZ629855A
(en)
|
2012-03-20 |
2016-01-29 |
Adamed Sp Zoo |
Sulphonamide derivatives of benzylamine for the treatment of cns diseases
|
|
RU2693480C2
(ru)
|
2013-03-14 |
2019-07-03 |
Толеро Фармасьютикалз, Инк. |
Ингибиторы jak2 и alk2 и способы их использования
|
|
JP6267334B2
(ja)
|
2013-07-25 |
2018-01-24 |
ユニベルシテット ヤギェウォＵｎｉｗｅｒｓｙｔｅｔ Ｊａｇｉｅｌｌｏｎｓｋｉ |
５−ｈｔ６拮抗薬としてのピロロキノリン誘導体、それらの製造方法および使用
|
|
US9840482B2
(en)
|
2014-04-19 |
2017-12-12 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367472B
(zh)
*
|
2014-08-12 |
2020-04-21 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN105367473B
(zh)
*
|
2014-08-12 |
2020-02-11 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
PL3242666T3
(pl)
|
2015-01-06 |
2025-02-17 |
Arena Pharmaceuticals, Inc. |
Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
|
|
RU2017145976A
(ru)
|
2015-06-12 |
2019-07-15 |
Аксовант Сайенсиз Гмбх |
Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
|
|
HUE060476T2
(hu)
|
2015-06-22 |
2023-03-28 |
Arena Pharm Inc |
(R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra
|
|
TW201720439A
(zh)
|
2015-07-15 |
2017-06-16 |
Axovant Sciences Gmbh |
用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物
|
|
CN108926565A
(zh)
*
|
2017-05-26 |
2018-12-04 |
中国科学院上海生命科学研究院 |
五羟色胺受体亚型6小分子激活剂及拮抗剂在防治阿尔茨海默症中的应用
|
|
WO2019180176A1
(en)
|
2018-03-21 |
2019-09-26 |
Spherium Biomed, S.L. |
Composition for the treatment of schizophrenia and/or psychosis
|
|
US12156866B2
(en)
|
2018-06-06 |
2024-12-03 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
CA3103995A1
(en)
|
2018-07-26 |
2020-01-30 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
|